Publications

1. Cariprazine (Reagila®) for the treatment of schizophrenia

   The Minister of Health, Welfare and Sport (WVS) asked the National Health Care Institute  (National Health Care Institute) to ...

   Report | 04-06-2018

2. Dimethyl fumarate (Skilarence®) for the treatment of plaque psoriasis in adults

   The Minister of Health, Welfare and Sport (WVS) asked Zorginstituut Nederland (National Health Care Institute) to carry out an ...

   Report | 09-05-2018

3. Flash Glucose Monitoring (FGM)

   In this report the National Health Care Institute assesses whether Flash Glucose Monitoring (FGM) complies with ‘established ...

   Report | 30-04-2018

4. Rolapitant (Varuby®) for the prevention of delayed nausea and vomiting associated with highly and moderately emetogenic cancer chemotherapy in adults

   The National Health Care Institute has carried out an assessment of the medicinal product rolapitant (Varuby®). The GVS report ...

   Report | 17-04-2018

5. Belimumab (Benlysta®) for the treatment of adult patients with auto-antibody-positive systemic lupus erythematosus (SLE)

   The National Health Care Institute has carried out an assessment of the medicinal product subcutaneous belimumab (Benlysta®) and ...

   Report | 29-03-2018

6. Fampridine (Fampyra®) in cases of multiple sclerosis (MS)

   The National Health Care Institute carried out an assessment of the medicinal product fampridine (Fampyra®). Based on the ...

   Report | 01-03-2018

7. Nusinersen (Spinraza®) for the treatment of 5q Spinal Muscular Atrophy

   The National Health Care Institute  carried out an assessment on the medicinal product nusinersen (Spinraza®) for the treatment ...

   Report | 07-02-2018

8. Evolocumab (Repatha®) for the treatment of hypercholeresterolaemia

   The National Health Care Institute  issued a package advice on the medicinal product evolocumab (Repatha®) for the treatment of ...

   Report | 18-01-2018

9. Cysteamine eyedrops (Cystadrops®) for the treatment of cystinosis

   Zorginstituut Nederland carried out an assessment of the medicinal product cysteamine (Cystadrops®). The viscous cysteamine HCL ...

   Report | 04-01-2018

10. Zinnige Zorg room for improvement report - Chest pain (Suspected) Stable Angina Pectoris

    The motto of the National Health Care Institute is "Taking care of good health care: no more and no less than necessary". Every ...

    Report | 17-12-2017